ADVFN - Advanced Financial Network.
HOME» NYSE » B » BCR Stock Price » BCR Stock News

Bard C R Share News

 Bard (c.r.), Inc. Stock Price
BCR Stock Price
 Bard (c.r.), Inc. Stock Chart
BCR Stock Chart
 Bard (c.r.), Inc. Stock News
BCR Stock News
 Bard (c.r.), Inc. Company Information
BCR Company Information
 Bard (c.r.), Inc. Stock Trades
BCR Stock Trades

CR Bard Voluntarily Recalls XenMatrix Surgical Graft Product

By Jon Kamp Of DOW JONES NEWSWIRES C.R. Bard Inc. (BCR) disclosed Tuesday that its Davol Inc. subsidiary has voluntarily recalled a surgical-graft product called XenMatrix that is used in hernia and abdominal wall repair. The medical-device maker said its previously issued guidance for the fourth quarter last year and full-year this year remains unchanged despite the recall. The company disclosed the event in a brief filing with the Securities and Exchange Commission, where it said the recall started on Friday. It did not describe a reason for the recall, and a spokesman could not be reached for immediate comment on the matter. Bard's shares traded up 26 cents to $91.31 early Tuesday. -By Jon Kamp, Dow Jones Newswires; 617-654-6728;

Stock News for Bard C R (BCR)
No Recent News Available

Bard C R and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations